Study of inherited cancer gene samples in blood and saliva
Part of Cancer clinical trials.
This study collects blood and saliva to look for inherited gene changes in people who have been diagnosed with cancer. It may help researchers understand what genetic risks could be involved, which could guide future cancer care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed cancer diagnosis from tissue (biopsy/surgery) or from clinical testing
- You can understand the study and agree to sign an informed consent form
- Your cancer diagnosis must be confirmable (not uncertain or unconfirmed)
- You must be willing to participate in sample collection (blood and saliva) after agreeing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at DNA patterns in families where cancer may run in families, to better understand inherited (passed-down) cancer risk. You may be able to help even if you’re not sure whether your cancer is genetic—your family history and, if needed, medical records or tumor samples can be used.
This study looks at the genetic information (DNA) from your blood and from saved tumor tissue to better understand certain cancers, especially rare cancers with a poor outlook. It may help researchers learn why these cancers behave the way they do and guide future treatments.
This study looks for cancer-related material in blood, urine, and sometimes bone marrow. It may help researchers understand how to detect cancer activity and track it over time using less invasive tests.
This study looks at the genes that may be linked to blood cancers. You provide a saliva sample and answer a health survey at home, and your DNA may help researchers understand why some people get blood cancers.
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
This study collects blood and tissue samples from people with cancer or suspected cancer, or from their blood relatives. Researchers use these samples to better understand cancer and develop new treatments.
Hear when a new Malignant Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.